tradmap

RGC Regencell Bioscience Holdings Ltd

$6.43 +3.38%

Updated

Healthcare · Medicinal Chemicals & Botanical Products

Regencell Bioscience Holdings Ltd (RGC) is a healthcare company in the Medicinal Chemicals & Botanical Products industry. Shares last traded at $6.43, 90.7% below their 52-week high. Over the past year the stock is down 53.5%.

Market Cap
Shares Out
EPS (TTM)
$-0.72
P/E Ratio
P/S Ratio
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$68.80
52-Week Low
$4.55
Volume
9,784
Avg Vol (3m)
9,674.032

Performance

1W
+16.91%
1M
+10.10%
3M
-71.27%
6M
-73.54%
YTD
-68.85%
1Y
-53.47%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
57.29
SMA (50)
$5.76
SMA (200)
$19.96
Price vs SMA50
+11.59%
Price vs SMA200
-67.78%
ATR (14)
$0.52

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
Net Income
$-4M
Gross Margin
Operating Margin
Net Margin
Return on Equity
-73.7%
Return on Assets
-62.3%
Current Ratio
7.39
Debt / Equity
0.18
Revenue Growth (YoY)

Full financials — revenue, cash flow & debt over time →

Medicinal Chemicals & Botanical Products peers

RGC vs 14 industry peers (Medicinal Chemicals & Botanical Products), by market cap. Updated

1–14 of 14
DFTXDefinium Therapeutics, Inc.$5.1B-14.43-2.40%
TRLVTrulieve Cannabis Corp.$2.3B-4.862.03-41.8%+2.56%
TLRYTilray Brands$616M-5.070.67-13.3%+0.11%
USNAUSANA HEALTH SCIENCES INC$267M-12.030.29-2.4%-1.30%
NAGENiagen Bioscience, Inc.$246M15.411.9112.4%-1.89%
FTLFFITLIFE BRANDS, INC.$93M14.860.916.2%-3.10%
BTMDbiote Corp.$46M7.820.253.2%-9.91%
MTEXMANNATECH INC$14M-1.900.13-6.9%-2.93%
NAIINATURAL ALTERNATIVES INTERNATIONAL INC$12M-0.860.09-10.1%-0.47%
SNYRSynergy CHC Corp.$2M-0.100.06-57.0%-2.03%
CRONCronos Group39.1%+0.46%
CGCCanopy Growth-80.4%+0.27%
GLASGlass House Brands Inc.-16.3%+3.61%
IMCCIM Cannabis Corp.-27.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.